Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5612211A · kind A · utility
81Cited by
7References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 15, 1993 |
| Grant date | Mar 18, 1997 |
| Priority date | — |
| Expiry date | Jun 15, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1394
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fibroblast growth factors are used in vivo, in situ and in vitro to stimulate stem cells, hemopoiesis, the immune system, transplant donor cells, culture and/or engraftment, wherein the use of fibroblast growth factors is disclosed for the stimulation of stem cells or hemopoietic cells, supporting cells and their progeny, in vitro, in situ and in vivo, as well as corresponding engrafting sites in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.